Clinical Trials Browser

OTHER × Ovarian Neoplasms × Thalidomide × Clear all

NCT00016224 2013-06-18

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms